Genetic lab pays doctors to push dubious tests

Genetic lab pays doctors up to $144K/yr to push dubious tests By CHARLES PILLER @cpiller  Feb 2017

For doctors, the brochure from a California medical laboratory sounded like easy money: $30 for every person enrolled in a study of genetic tests meant to help select the best pain medication for each patient. A typical physician could make $144,000 a year in “research fees.”

But the clinical trial was largely a ploy to boost Proove Biosciences’s revenues, and many of the doctors who signed up did no actual work, say current and former employees.

Proove has grown rapidly by tapping into the public angst over surging opioid addiction.  

It is one of many companies touting personalized DNA-based tests backed by little or no credible scientific data showing their reliability.

That’s because a regulatory loophole has left huge swaths of the multibillion-dollar genetic testing industry largely free of government oversight.

A STAT investigation found that Proove employees stationed in physicians’ offices pushed unnecessary tests on patients — a practice called “coercion” by one former manager — and they sometimes completed research evaluation forms on behalf of doctors, rating the tests as highly effective when they weren’t.

In fact, Proove tests of DNA captured by swabbing inside a patient’s cheek were so unreliable that many physicians disregarded the results.

There was scant evidence, said the company’s former chief scientist, that the tests improved patient outcomes.

The company, located in two modern buildings in a burgeoning life sciences corridor in Irvine, Calif., also billed insurers in misleading ways to bump up payments, according to current and former employees and copies of insurance forms.

Promoting itself as the “leader in personalized pain medicine,” Proove claims its tests predict how patients will react to pain medicines and who might become dependent on opioids.

The company has enjoyed glowing television news coverage suggesting it can help combat the opioid crisis.

Current and former employees and doctors who worked with Proove called such portrayals the product of hype generated by CEO Brian Meshkin, who lacks a background in science and is known for his consummate sales abilities and talent for self-promotion.

The government has been concerned about companies marketing tests under the guise of research for several years.

In 2014, HHS issued a fraud alert warning laboratories that some ways of paying doctors for “research” might violate laws against kickbacks for lab test referrals. The alert followed a spate of cases involving allegedly improper payments to doctors by laboratory companies

In response to the HHS alert, Proove’s legal counsel drafted a memo6 for executives and sales staff stipulating that company practices complied with the law.

Among other arguments, it said Proove compensates doctors only for research they personally perform. But current and former employees and doctors who worked with Proove have since disputed that claim.

The Food and Drug Administration warned in 2015 that some laboratory developed tests harm patients by leading to erroneous diagnoses and treatments.

But the agency withdrew proposed regulatory guidelines for these tests late last year, deferring to President Trump’s yet-to-be named FDA commissioner and Congress to decide what, if any, rules to put in place.

For now at least, Proove and similar companies can sell tests without having to show that results are valid and meaningful. STAT obtained Proove laboratory reports9 with gene-test results for six patients that included numerous incompatible clinical recommendations.

A push to swab every patient

The questionable science hasn’t stopped Meshkin from building the privately held Proove into what Deloitte Consulting and Inc. magazine call one of the nation’s fastest-growing businesses.

His formula is simple: recruit doctors as paid “researchers,” providing them with a financial stake in ordering tests for their patients.

 

Advertisements

3 thoughts on “Genetic lab pays doctors to push dubious tests

  1. Emily Raven

    I love how stuff like this is pushed and even GP’s partake in it… Awhile ago it was cancer and diabetes genetic screening… And two months after trying to push those two on me a test for Ehlers Danlos which I most certainly have unless it’s Marfans (highly unlikely) was “just too difficult… I can’t order that.”

    Follow the money. Here’s an idea: make what drug reps do illegal completely. Like for real, period. No rules, it’s just a no no now. And then doctors can read about stuff and actually learn the ins and outs like the rest of us poor uneducated schmucks.

    Like

    Reply
  2. Kathy C

    It doesn’t have to work they just have to Marketing as is of it does. We are now so resistant to facts anymore, Even asking for facts is a Crime. This Companies seized on popular narratives and used them in the Marketing Campaign. The Healthcare Industry no longer relies on Facts or even Evidence Based Science, They even have Physicians peddling “Alternative Medicine”

    Liked by 1 person

    Reply
    1. Zyp Czyk Post author

      I’m shocked that reiki is being offered as an alternative to medication – but only for pain, of course.

      They wouldn’t dare use reiki to treat diabetes or high blood pressure or heart disease.

      Like

      Reply

Other thoughts?

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s